title: Cuba's National Clinical Trials Coordinating Center: emergence, evolution, and main results. Translated from the Spanish and reprinted with permission from the Revista Cubana de Farmacia. Vol. 44 No. 2 (special supplement), Apr-Jun 2010.
abstract: The rapid development of Cuba's pharmaceutical industry in the 1990s created a need for structures to ensure clinical evaluation of products before their introduction into medical practice and subsequent marketing. One of the centers founded for this purpose was the National Clinical Trials Coordinating Center. This paper summarizes the factors that motivated the creation of the Center and presents a brief history of its organizational development over the last 17 years. It also describes the main components of the system for designing and conducting clinical trials, and the most significant contributions of each toward achieving the Center's objectives.
authors.affiliation: National Clinical Trials Coordinating Center, Havana, Cuba. map@infomed.sld.cu
authors.forename: María A Pascual
authors.initials: MA
authors.lastname: López
authors.forename: Gladys Jiménez
authors.initials: GJ
authors.lastname: Rivero
authors.forename: Ania Torres
authors.initials: AT
authors.lastname: Pombert
authors.forename: Martha María Fors
authors.initials: MM
authors.lastname: López
authors.forename: Isabel López
authors.initials: IL
authors.lastname: Zayas
mesh_terms: D035843:Biomedical Research; D002986:Clinical Trials as Topic / Q000379:methods*; D003284:Contract Services; D003462:Cuba; D004341:Drug Evaluation / Q000379:methods*; D004345:Drug Industry / Q000379:methods*; D006801:Humans